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Likelihood of Having Self-Injectable Epinephrine
in Adult and Pediatric Patients Presenting for
Evaluation of Food Allergy

Carolyn H. Baloh, MD1, Daniel Winger, MS2, Tara Shankar, MD3,
Merritt L. Fajt, MD3, Todd David Green, MD, FAAAAI1; 1Children’s
Hospital of Pittsburgh of UPMC, Pittsburgh, PA, 2UPMC, 3University
of Pittsburgh Medical Center, Division of Pulmonary, Allergy and Critical
Care Medicine, Pittsburgh, PA.
RATIONALE: Food allergy is a leading cause of anaphylaxis, and
underprescription of epinephrine is well documented; we were interested
in comparing trends related to this in pediatric and adult populations at one
academic medical center.
METHODS: Retrospective chart review of 100 pediatric and 222 adult
patients seen at Children’s Hospital of Pittsburgh of UPMC or UPMC for a
diagnosis of food allergy June 15, 2004 through June 15, 2014. 53 adult and
26 pediatric patients were excluded. Final adult n: 169. Final pediatric n:
74. This review was IRB exempt approved.
RESULTS: 64% of adults and 58% of children seen by a physician for
food allergy had self-injectable epinephrine prior to their first allergy visit.
Adults referred by a PCP were significantly less likely to have epinephrine
(p50.036) than those seen by another physician, with a similar trend in
children (p50.070). 62% of adults and 86% of children previously treated
with epinephrine for anaphylaxis had self-injectable epinephrine. Children
(p50.002) and adults (p50.034) with tree nut allergy were more likely to
have epinephrine than those with a different food allergy, including peanut.
Peanut-allergic adults were more likely to have epinephrine (p50.007).
Milk-allergic children were less likely to have epinephrine (p50.03), as
were adults with fruit allergy (p50.008). 42% of children avoiding 3 or
more foods had epinephrine while 66% avoiding less than 3 foods had
epinephrine (p50.047), a trend not seen with adults.
CONCLUSIONS: Adult and pediatric patients presenting to an allergist
for food allergy have a lower than optimal rate of having self-injectable
epinephrine.
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Recurrent Idiopathic Anaphylaxis in a Woman
after Suspected Food Poisoning

Carl B. Lauter, MD, FAAAAI; Beaumont Health System, Royal Oak,
MI.
RATIONALE: Recurrent idiopathic anaphylaxis represents a vexing
clinical problem associated with stress for patients and allergists. The
cause is often not identified despite exhaustive testing.
METHODS: The history of a 54-year-old woman with repeated bouts of
unexplained anaphylaxis is reviewed. The relationship between preceding
or active infection (emphasis on GI infections) and chronic idiopathic
urticaria (CIU) and anaphylaxis was explored by electronic media search
(PubMed, Google) and review of reference lists of published articles. The
literature on the relationship of Campylobacter jejuni, infection and urticaria is reviewed. Gastrointestinal infections (Giardia, Anisakis) have
been better documented in such patients.
RESULTS: The patient had persistent flatulence, looser and more frequent
bowel movements for months after recovery from a bout of food poisoning.
A diagnosis of ‘‘post infectious irritable bowel syndrome’’ was made by a
gastroenterologist. These symptoms were not related to her simultaneous
diagnosis of CIU and idiopathic anaphylaxis. After treatment with
azithromycin (positive stool culture for Campylobacter jejuni) she had a
systemic allergic reaction. Subsequently, the diarrhea and urticaria/
anaphylaxis cleared. Campylobacter jejuni has been reported to cause
chronic urticaria, but predominantly in children. A related organism,
Helicobacter pylori, has been associated with CIU. Anaphylaxis has not
been related to Campylobacter, infection in the past.
CONCLUSIONS: Chronic urticaria and recurrent bouts of mild unexplained anaphylaxis were triggered by Campylobacter jejuni infection. The
allergic and GI symptoms resolved after treatment. Gastrointestinal infections should be looked for in patients with urticaria or anaphylaxis.
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An Interdisciplinary Approach to Perioperative
Anaphylaxis: A Tertiary Pediatric Center
Experience

Atoosa Kourosh, MD, MPH, Karen Thursday S. Tuano, MD, Dipika
Patel, MD, Nicholas Rider, DO, Sara Anvari, MD, Lenora M.
Noroski, MD, MPH, Kristin H. Dillard, MD, Filiz O. Seeborg, MD,
MPH; Baylor College of Medicine and Texas Children’s Hospital, Department of Pediatrics, Section of Immunology, Allergy and Rheumatology,
Houston, TX.
RATIONALE: The estimated incidence of peri-operative anaphylaxis
(PA) is 1:3,500-1:20,000. Although rare, PA causes morbidity and poses
significant risk of mortality (3-9%). The most common causal agents are
neuromuscular blocking agents, antibiotics and latex. In the operative
setting, patients are exposed to multiple intravenous, inhaled and topical
agents in rapid succession. Unless the cause of PA is quickly identified
necessary procedures will be delayed.
METHODS: Retrospective chart review for one year at Texas Children’s
Hospital included 8 patients with confirmed PA (5 cardiac, 1 dental, 1
radiology, 1 tonsillectomy). Skin prick and intradermal testing (ST) were
performed with exposed agents and additional medications in collaboration with surgery teams for upcoming surgeries.
RESULTS: Most common presenting symptoms were bronchospasm,
hypotension and urticaria. Positive ST were found to Vecuronium,
Cefazolin, Vancomycin, Midazolam, Ketamine, Methylprednisolone,
Triamcinolone, Chlorhexidine, Fentanyl and Morphine. Vancomycin and
Triamcinolone were not exposures but tested prior to upcoming procedures
based on collaborative plans. Of 3 patients ST positive to opioids, 2
subsequently tolerated Morphine challenge. Vecuronium, Cefazolin,
Midazolam, Ketamine, Chlorhexidine and Methylprednisolone were
identified as true causal agents and avoided.
CONCLUSIONS: In addition to common causal agents in PA, more
unusual agents like steroids and topical agents besides latex should also be
investigated. Since drugs such as Vancomycin and opioids can produce
false positive ST, graded challenge may be required to validate ST when
alternatives are unavailable. An interdisciplinary team approach with close
collaboration between allergy, anesthesia and surgical teams is key to
planning the diagnostic work-up and advancing to surgery safely and
expeditiously.
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